My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 66

    1.

    Systemic blockade of the hyaluronan receptor for endocytosis prevents lymph node metastasis of prostate cancer.

    Simpson MA, Weigel JA, Weigel PH.

    Int J Cancer. 2012 Jan 10. doi: 10.1002/ijc.27427. [Epub ahead of print]

    PMID:
    22234863
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Weight change and prostate cancer incidence and mortality.

    Bassett JK, Severi G, Baglietto L, Macinnis RJ, Hoang HN, Hopper JL, English DR, Giles GG.

    Int J Cancer. 2011 Dec 31. doi: 10.1002/ijc.27414. [Epub ahead of print]

    PMID:
    22213024
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case-control study.

    Nair-Shalliker V, Smith DP, Egger S, Hughes AM, Kaldor JM, Clements M, Kricker A, Armstrong BK.

    Int J Cancer. 2011 Dec 15. doi: 10.1002/ijc.27400. [Epub ahead of print]

    PMID:
    22173996
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Estimated phytanic acid intake and prostate cancer risk: A prospective cohort study.

    Wright ME, Bowen P, Virtamo J, Albanes D, Gann PH.

    Int J Cancer. 2011 Nov 28. doi: 10.1002/ijc.27372. [Epub ahead of print]

    PMID:
    22120496
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer In Vivo.

    Lee JB, Zhang K, Tam YY, Tam YK, Belliveau NM, Sung VY, Lin PJ, Leblanc E, Ciufolini MA, Rennie PS, Cullis PR.

    Int J Cancer. 2011 Nov 16. doi: 10.1002/ijc.27361. [Epub ahead of print]

    PMID:
    22095615
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell.

    Zhang X, Song Y, Wu Y, Dong Y, Lai L, Zhang J, Lu B, Dai F, He L, Liu M, Yi Z.

    Int J Cancer. 2011 Nov 15;129(10):2502-11. doi: 10.1002/ijc.25909. Epub 2011 Apr 7.

    PMID:
    21207415
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening.

    Wu GH, Auvinen A, Määttänen L, Tammela TL, Stenman UH, Hakama M, Yen AM, Chen HH.

    Int J Cancer. 2011 Nov 2. doi: 10.1002/ijc.27340. [Epub ahead of print]

    PMID:
    22052356
    [PubMed - as supplied by publisher]

    Related citations

    8.

    Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.

    Gilbert R, Metcalfe C, Fraser WD, Donovan J, Hamdy F, Neal DE, Lane JA, Martin RM.

    Int J Cancer. 2011 Oct 27. doi: 10.1002/ijc.27327. [Epub ahead of print]

    PMID:
    22033893
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model.

    Shanmugam MK, Manu KA, Ong TH, Ramachandran L, Surana R, Bist P, Lim LH, Kumar AP, Hui KM, Sethi G.

    Int J Cancer. 2011 Oct 1;129(7):1552-63. doi: 10.1002/ijc.26120. Epub 2011 Jul 20.

    PMID:
    21480220
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer.

    Zhao Z, Zeng G, Ma W, Ou L, Liang Y.

    Int J Cancer. 2011 Sep 27. doi: 10.1002/ijc.26459. [Epub ahead of print]

    PMID:
    21952944
    [PubMed - as supplied by publisher]

    Related citations

    11.

    Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation.

    Van Hemelrijck M, Jungner I, Walldius G, Garmo H, Binda E, Hayday A, Lambe M, Holmberg L, Hammar N.

    Int J Cancer. 2011 Sep 15;129(6):1485-92. doi: 10.1002/ijc.25773. Epub 2011 Jan 12.

    PMID:
    21792885
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    A gene signature identified using a mouse model of androgen receptor-dependent prostate cancer predicts biochemical relapse in human disease.

    Thompson VC, Day TK, Bianco-Miotto T, Selth LA, Han G, Thomas M, Buchanan G, Scher HI, Nelson CC; the Australian Prostate Cancer BioResource, Greenberg NM, Butler LM, Tilley WD.

    Int J Cancer. 2012 Aug 1;131(3):662-672. doi: 10.1002/ijc.26414. Epub 2012 Jan 24.

    PMID:
    22275114
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells.

    Ciarlo M, Benelli R, Barbieri O, Minghelli S, Barboro P, Balbi C, Ferrari N.

    Int J Cancer. 2012 Aug 1;131(3):582-90. doi: 10.1002/ijc.26402. Epub 2011 Oct 20.

    PMID:
    22015967
    [PubMed - in process]

    Related citations

    14.

    Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease.

    Selth LA, Townley S, Gillis JL, Ochnik AM, Murti K, Macfarlane RJ, Chi KN, Marshall VR, Tilley WD, Butler LM.

    Int J Cancer. 2012 Aug 1;131(3):652-61. doi: 10.1002/ijc.26405. Epub 2011 Nov 3.

    PMID:
    22052531
    [PubMed - in process]

    Related citations

    15.

    Dietary acrylamide and risk of prostate cancer.

    Wilson KM, Giovannucci E, Stampfer MJ, Mucci LA.

    Int J Cancer. 2012 Jul 15;131(2):479-87. doi: 10.1002/ijc.26383. Epub 2011 Sep 14.

    PMID:
    21866549
    [PubMed - in process]

    Related citations

    16.

    miR 488* inhibits androgen receptor expression in prostate carcinoma cells.

    Sikand K, Slaibi JE, Singh R, Slane SD, Shukla GC.

    Int J Cancer. 2011 Aug 15;129(4):810-9. doi: 10.1002/ijc.25753.

    PMID:
    21710544
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    Vegetable and fruit intake after diagnosis and risk of prostate cancer progression.

    Richman EL, Carroll PR, Chan JM.

    Int J Cancer. 2012 Jul 1;131(1):201-10. doi: 10.1002/ijc.26348. Epub 2011 Aug 30.

    PMID:
    21823116
    [PubMed - in process]

    Related citations

    18.

    Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

    Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.

    Int J Cancer. 2012 Jun 15;130(12):2812-23. doi: 10.1002/ijc.26284. Epub 2011 Aug 30.

    PMID:
    21780100
    [PubMed - in process]

    Related citations

    19.

    Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells.

    Okamoto R, Delansorne R, Wakimoto N, Doan NB, Akagi T, Shen M, Ho QH, Said JW, Koeffler HP.

    Int J Cancer. 2012 May 15;130(10):2464-73. doi: 10.1002/ijc.26279. Epub 2011 Aug 27.

    PMID:
    21732345
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    ARFGAP3, an androgen target gene, promotes prostate cancer cell proliferation and migration.

    Obinata D, Takayama K, Urano T, Murata T, Ikeda K, Horie-Inoue K, Ouchi Y, Takahashi S, Inoue S.

    Int J Cancer. 2012 May 15;130(10):2240-8. doi: 10.1002/ijc.26224. Epub 2011 Sep 22.

    PMID:
    21647875
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk